Loading company…
OCON Therapeutics develops intrauterine medical devices for contraception and treatment of women's health conditions.
Founded in 2011 and based in Modiin, Israel, OCON Therapeutics develops intrauterine technologies including the hormone-free IUB Ballerine contraceptive device, IUB SEAD for abnormal uterine bleeding and IUB PRIMA for conditions such as endometriosis and myomas. In June 2024, it raised USD 10.000 mn led by RHV Capital, with other investors including Astia Angels and Features Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in